Deeptech factory

THERAPANACEA

Unlocking the full potential of cancer treatment and care with artificial intelligence

TheraPanacea is a software solutions editor using AI to transform cancer care through prognosis and treatment solutions.

CEO: Nikolaos Paragyios

Creation: march 2017

Headcount: 75

Location: Paris

Market(s) : Radiotherapy / Oncology

www.therapanacea.eu

#AI #Cancer #PrecisionMedecine

TECHNO / PRODUCTS

TheraPanacea is reinventing cancer care with cutting-edge technologies based on artificial intelligence and a holistic, precision approach. Inspired by information theory and digital medicine, TheraPanacea acts on all scales – macro, micro and nano – to offer more targeted, more effective and truly personalized treatments for each patient.

PRODUCTS PORTFOLIO

  • ART-PlanTM
  • SmartFuse
  • Annotate
  • MR-Box
  • AdaptBox
  • TumorBox
  • SmartPlan

APPLICATIONS

TheraPanacea is a highly ambitious artificial intelligence-powered French spinoff medical technology company exploiting state-of-the-art research technology with origins from Ecole CentraleSupelec, Inria and Gustave Roussy Institute.

TheraPanacea brings to the radiation therapy market the latest inter-disciplinary technological advances from the associated research laboratories (machine learning, AI, advanced mathematics).

BENEFITS

TheraPanacea benefits:
– 100% web solution (technologie Cloud)
– Ready-to-use plug and play at hospitals
– Up to 90% of expert time gained in fastidious hence critical operations
– L18Smart automation (deep-learning one-click solutions)

THERAPANACEA MINUTE